by PRI | Jun 21, 2022 | Non classé
Ana Montalban-Arques CEO Recolony Recolony focuses on the development of a live biotherapeutic product for the treatment or prevention of colorectal cancer....
by PRI | Jun 20, 2022 | Non classé
Pascaline Gervoson CEO PiLeJe’s purpose is to promote the health of each individual and maintain it for as long as possible. This is achieved by applying what Dr Christian Leclerc, the Group’s founder, calls “health-based medicine”....
by PRI | Jun 17, 2022 | Non classé
Debra Barker CMO Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention....
by PRI | Jun 17, 2022 | Non classé
Aurélien Baudot CEO Early & late preclinical research for a fast & informative gut microbiome product development....
by PRI | Jun 17, 2022 | Non classé
Mo Langhi Director, Business Development CosmosID® is a global leader in supporting the pharmaceutical sector with CLIA-certified, ICH-GCP compliant microbiome and microbial isolate solutions for applications such as pre-clinical, clinical, CMC and regulatory support....
by PRI | Jun 17, 2022 | Non classé
Oliver Ravn Marketing and Market Intelligence Associate Leading CDMO in the LBP industry...
